Coblopasvir
Coblopasvir is a pan-genotypic NS5A inhibitor used to study Hepatitis C virus infection. It is applied in both in vitro and in vivo research to investigate viral replication mechanisms and evaluate potential antiviral therapies for chronic HCV.
Product Specifications
CAS Number
1312608-46-0
Product Name Alternative
Chronic hepatitis C virus infection, Coblopasvir, Inhibitor, Hepatitis C virus, HCV, HCV Protease, inhibit, NS5A, KW 136, KW136, KW-136, pangenotypic regimen
Field of Research
Infectious Disease & Virology, Protein Biochemistry
Purity
99.33% (May vary between batches)
Smiles
C ([C@@H] (NC (OC) =O) C (C) C) (=O) N1[C@H] (C=2NC (C3=C4C (=C (C=C3) C5=CC=C (C=C5) C=6NC (=NC6) [C@H]7N (C ([C@@H] (NC (OC) =O) [C@@H] (C) C) =O) CCC7) OCO4) =CN2) CCC1
Molecular Formula
C41H50N8O8
Molecular Weight
782.88
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
